-
Study aim
-
Comparison of the effect of topical gel containing Sambucus ebolus extract compared with placebo on reducing itching complications in hemodialysis patients
-
Design
-
A randomized, controlled, single-blind, placebo-controlled clinical trial
-
Settings and conduct
-
A randomized, controlled, single -blind, placebo-controlled clinical trial
The person evaluating the severity of the itch is unaware of the product
The dialysis centers of the citizens of Sari and Imam Reza Amol are performed.The sample size is 150 patients.The person evaluating the severity of the itch is unaware of the product.Due to the special color and smell of herbal products, it is not possible to blind the patient.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:Patients over 18 years who have been undergoing hemodialysis for more than 3 months,
Patients who have had itching at least 3 times in the last 2 weeks,
Despite drug use in the last month of treatment, no evidence of improvement was observed,
Patients undergo hemodialysis 3 days a week for 3–5 hours per session,
Have no skin problems other than uremic itching,
Patients who gave their written consent to participate in the project,
Patients who do not use another method to reduce their severity,
Lack of systemic diseases such as liver cholestatic, hepatitis B, HIV thyroid disorders and women who are not pregnant and breastfeeding,
Lack of cognitive impairments that cannot answer questions,
Exclusion criteria:
If the patient undergoes kidney transplantation during the study,
If allergic to sambucus ebulus gel,
Patients who do not wish to continue the study for personal reasons,
Patients suffering from P tests above 6 and PTH more than 300
-
Intervention groups
-
Group A: sambucus ebulus gel, Group B: Placebo gel, Group C: Control (without intervention)
-
Main outcome variables
-
pruritus